TGF-β has been found to be an atheroprotective factor in arteriosclerosis [25], and the TGF-β/Smad pathway can suppress NF-kB activation-induced inflammation by blocking TAB2 or TAB3 [26]. Here, TAB3 is linked to arteriosclerosis.